| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | -0.071 | 0.04 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | -0.08 | 0.04 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | 0.087 | 0.04 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.063 | 0.04 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.04 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | -0.081 | 0.04 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.068 | 0.04 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.04 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.067 | 0.04 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.04 |